In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlaxoSmithKline Consumer Healthcare

Division of GlaxoSmithKline PLC
us.gsk.com

Latest From GlaxoSmithKline Consumer Healthcare

German Expert Panel Opposes OTC Ibuprofen/Phenylephrine Combo, Hydrocortisone 1%

Two prescription-to-OTC switch applications rejected by Germany’s Expert Committee for Prescription: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.

Health OTC Drugs

Romania’s OTC Market in 2018: Colds And Flu Epidemic Help Boost Sales By 14%

Romanian self-care industry association, RASCI, provides HBW Insight with an exclusive viewpoint on the country's OTC market in 2018. 

 

Health OTC Drugs

Germany Begins The Year With Two Possible Rx-To-OTC Switches

Germany's Expert Committee for Prescription will meet on 22 January to consider two prescription-to-OTC switch applications: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use. 
Health OTC Drugs

GSK Invests In OTC Production, Prepares To Divest Horlicks Nutritional Business

Latest consumer health investment was $36m upgrade to a Canadian facility, which by mid-2019 will begin making Voltaren OTC topical gel products. GSK's next move in consumer health divestment is its pending sale of its Horlicks business.

M & A Canada
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register